Kinga Miaśkiewicz
Maria Janiak2
Marcin Folwarski- 1Department of Paediatrics, Gastroenterology, Allergology and Nutrition, Medical University of Gdańsk, Gdańsk, Poland
- 2Department of Gastroenterology and Hepatology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
- 3Department of Clinical Nutrition and Dietetics, Medical University of Gdańsk, Gdańsk, Poland
- 4Home Enteral and Parenteral Nutrition Unit, Nicolaus Copernicus Hospital, Gdańsk, Poland
Intractable hiccups, lasting over a month, can severely impair quality of life and, in rare cases, significantly limit the ability to maintain adequate oral nutritional intake. We report a 63-year-old male with a 5-year history of intractable hiccups, 30 kg weight loss (37%), muscle wasting, and functional decline. Extensive diagnostics found no clear cause, and multiple therapies failed. Severe oral intake difficulties prompted initiation of enteral nutrition via PEG with jejunal extension (PEG-PEJ), resulting in a 15 kg weight gain and functional recovery over 6 months. One year later, during a hiccup relapse, the jejunal tube was dislodged. With gastric access intact, we transitioned to gastric feeding, which was well tolerated despite persistent hiccups. This case underscores that malnutrition may be a significant and underrecognized complication in chronic hiccups, with no established nutritional strategies described. Our experience suggests gastric feeding may be feasible in such patients. Further research is needed to guide management.
Introduction
Hiccups are sudden involuntary contractions of the diaphragm and intercostal muscles followed by abrupt glottic closure, producing the characteristic “hic” sound (1). Numerous factors can contribute to hiccups, including organic causes, psychogenic triggers, idiopathic origins, and those induced by medications (2). Moreover, intractable hiccups may indicate the presence of serious underlying medical issues (3). While most hiccup episodes resolve within 48 h, those lasting more than 1 month are classified as intractable (1). Chronic hiccups can severely impair oral intake, sleep, communication, and overall quality of life (1, 4). Fatigue, dehydration, and weight loss may occur, and in severe cases, can result in death (5, 6). We present a case of a 63-year-old man who was referred to the Home Nutrition Outpatient Clinic due to severe malnutrition that had progressively worsened because of intractable hiccups.
Case report
A 63-year-old man was referred to our Home Nutrition Outpatient Clinic for management of severe malnutrition following a five-year history of intractable hiccups. He reported progressive postprandial vomiting and inability to maintain adequate oral intake, resulting in a 30 kg (37%) weight loss. On assessment, his body weight was 51 kg with a height of 170 cm, corresponding to a BMI of 17.6 kg/m2, classifying him as severely malnourished according to GLIM criteria (7). Physical examination revealed profound muscle wasting, generalized weakness, poorly developed subcutaneous fat stores, and significant difficulty in walking due to reduced muscle strength. Bioimpedance analysis was not performed due to equipment unavailability; however, clinical findings were consistent with severe sarcopenia.
Hiccups had a considerable impact on the patient’s quality of life. Due to the persistent nature of his hiccups, he experienced difficulties in speaking and communication. He also suffered from depression, low mood, and fatigue. Hiccups occurred both during the day and at night. The only relief he found was by triggering his vomiting reflex with deep insertion of a toothbrush into his throat, which alleviated the symptoms for approximately 1 to 1.5 h and allowed him to fall asleep.
His medical history included gastroesophageal reflux disease (GERD), hypertension, hypercholesterolemia, gout, leukoaraiosis, and previously excised nasal squamous cell carcinoma. He had a 40-year smoking history (now e-cigarette use) and a history of alcohol abuse, consuming 1–2 beers daily. An extensive diagnostic workup was conducted 1 year prior to his admission to the Nutrition Unit, during hospitalization in the Gastroenterology and Hepatology Department. Laboratory investigations excluded metabolic causes, including electrolyte disturbances and diabetes. Gastroscopy confirmed gastropathy and reflux esophagitis. Chest CT and abdominal MRI excluded thoracic and abdominal structural lesions. Neurological evaluation, including head CT and MRI, demonstrated an elongated left vertebral artery compressing the ventral-left medulla oblongata, and nerve conduction studies revealed axonal damage to the left phrenic nerve with no primary cause (no compression or injury) and considered as a probable result of chronic hiccup. Psychiatric assessment excluded psychogenic causes. A complete list of diagnostic tests performed and conditions excluded is provided in Table 1. Despite this comprehensive evaluation, no single definitive treatable etiology was identified. Prior treatments included proton pump inhibitors (PPIs, used continuously from symptom onset and ongoing), haloperidol (3 months, discontinued due to lack of sustained effect), baclofen (3 weeks, discontinued), carbamazepine (1 month, discontinued due to lack of response), and metoclopramide (1 month, discontinued as it failed to control vomiting). Non-pharmacological approaches, including the Forced Inspiratory Suction and Swallow Tool (FISST) (27), provided only transient relief. Phrenic nerve ablation was discussed with the patient as a potential intervention. However, after careful consideration of the associated risks, including permanent diaphragmatic paralysis with potentially significant respiratory compromise, the patient declined this procedure.
Table 1. Diagnostic evaluation tests done to identify the primary cause of hiccups.
After referral to our Home Nutrition Unit, immediate intervention was warranted due to severe malnutrition. Oral nutritional supplements and dietary fortification failed to improve intake because of ongoing gastrointestinal symptoms. Enteral tube feeding was therefore recommended; however, uncontrolled diaphragmatic contractions posed a high risk of aspiration and vomiting with gastric feeds. A review of the literature suggested that esophageal manometry during acute hiccup episodes often demonstrates suppressed peristalsis and transient lower esophageal sphincter relaxation1, compromising gastric feeding safety (1). Consequently, we proceeded with placement of a percutaneous endoscopic gastrostomy with jejunal extension (PEG-PEJ). Given the severity of malnutrition and the risk of refeeding syndrome, jejunal feeding was initiated cautiously using an oligomeric (semi-elemental) normocaloric formula via continuous pump infusion, starting at 50% of estimated energy requirements. The rate was gradually increased over 5 days to achieve 100% of calculated needs. Serum electrolytes (potassium, phosphate, magnesium) and clinical status were monitored daily during the initiation phase. Once stable, the patient transitioned to a polymeric high-protein formula (Isosource Protein 2.0), administered as 1 liter daily via continuous pump infusion at the speed of 100 mL/h, providing 2000 kcal and 100 g of protein. PPI therapy was continued throughout for GERD management. This regimen resulted in a marked nutritional response: over 6 months, the patient’s body weight increased by 15 kg, and muscle strength improved sufficiently to permit daily physical activity.
At 1 year post-placement, during a prolonged hiccup episode accompanied by nausea and vomiting, the jejunal part dislodged and retrogradely traversed the gastrointestinal tract—passing from the jejunum into the esophagus—and its distal tip protruded into the oral cavity. The patient, mistaking it for a foreign object, manually extracted the jejunal extension, fracturing its distal segment. Remarkably, he remained asymptomatic. Endoscopic evaluation confirmed the integrity of the gastric component. Following a discussion with the patient, the decision was made to continue with gastric feeding alone, without jejunal extension. An oligomeric formula was briefly used during the transition period, followed by continuation of the polymeric high-protein formula using the same continuous pump infusion method. The patient experienced occasional heartburn, which was effectively managed with PPIs. Importantly, hiccup-induced vomiting did not interfere with enteral nutrition, allowing for stable weight and continued improvement in muscle function.
Discussion
Most hiccups are acute and self-limiting, resolving either spontaneously or with simple interventions within 48 h. Hiccups persisting beyond 48 h are classified as persistent, while those exceeding 1 month are termed intractable (3). While the overall incidence and prevalence of hiccups remain unclear, a cross-sectional study conducted over a 14-year period in the United States identified 66,124 emergency room patients who were subsequently admitted with hiccups documented as a discharge diagnosis. This translated to an average of 4,723 hospitalizations per year (SD ± 937) and an incidence rate of 632 cases per million hospital discharges. Among these patients, 895 were primarily admitted for hiccups as their main diagnosis with a rate of 8.4 per million hospital discharges (8). While this study from the Nationwide Inpatient Sample (NIS) indicated that the number of hospital admissions for hiccups as a primary diagnosis was relatively low, it was noteworthy that hiccups were documented as a secondary diagnosis in thousands of hospital admissions each year, and hiccups may not always have been recorded. Although hiccups were rarely diagnosed in hospitalized patients, this data underscored the importance of conducting a thorough investigation into this symptom (8). In the present case, two likely etiologies converged: gastroesophageal reflux disease (GERD), which manifests atypically as hiccups in ~4.5% of cases (9), and a history of carbonated alcohol intake, another recognized trigger (2, 10).
Treatment of hiccups should prioritize addressing the underlying cause whenever possible. If no specific pathology was identified or if a definitive treatment was not available, various pharmacological and non-pharmacological therapies had been proposed (3). Physical maneuvers and agents targeting dopaminergic or GABAergic pathways have been widely used, yet a recent systematic review highlighted the paucity of high-quality trials to guide practice (1). Acupuncture was proposed as a treatment for persistent and intractable hiccups, supported by several studies. However, these investigations, including four randomized controlled trials (n = 305), were limited by a lack of blinding or placebo controls, exhibited a high risk of bias, and failed to report potential side effects. This raised concerns about the true efficacy of acupuncture compared to placebo (11). The literature indicated that hypnosis (12) and upper endoscopy (13) had been explored as management strategies for persistent hiccups. Invasive procedures had been used for intractable hiccups unresponsive to medication (1). Given that vagal maneuvers could sometimes terminate hiccups (14), vagus nerve stimulation had emerged as a therapeutic option for intractable cases (15). This typically involved implantation of a vagus nerve stimulator (VNS) (16). Vagus nerve stimulation has produced complete relief in approximately 71% of seven published cases (15, 17). Phrenic nerve disruption may have been considered in patients with persistent hiccups that cause considerable discomfort or lead to significant morbidity. Temporary phrenic nerve block with long-acting anesthetic, such as bupivacaine is advised before considering permanent phrenic nerve disruption (18). An alternative approach involved the stellate ganglion’s (SG) role in the “reflex arc” of hiccups, where neural inhibition of the SG could interrupt the reflex (19). The injected drug likely spread to the vagus nerve, potentially blocking the phrenic nerves, anterior scalene muscle, and recurrent laryngeal nerves, thereby halting hiccups in these patients. Following the procedure, both the frequency and intensity of hiccups decreased, eventually leading to complete resolution in small series (20). Combining phrenic nerve block with stellate ganglion block may offer synergistic benefit (21). Additionally, a single-center randomized trial suggests that tailored breathing and water-drinking exercises may rival pharmacotherapy in efficacy and safety (22).
Although hiccups have been associated with oral intake difficulty and modest weight loss (2, 5, 23–25), no prior reports describe severe malnutrition directly attributable to intractable hiccups. Malnutrition is frequently underdiagnosed and undertreated, with profound adverse effects on physical function, mental health, and overall clinical outcomes (26).
This case report highlights that patients with a clinical diagnosis of hiccups may suffer from secondary severe malnutrition requiring nutritional support, including enteral nutrition. To our knowledge, there is currently no literature available regarding the potential routes for enteral nutrition in such cases, specifically whether feeding can be administered via gastric or intestinal access. The patient’s case demonstrated that gastric feeding was effective; however, it should be noted that feeding methods may depend on the underlying cause of the hiccup.
Conclusion
Intractable hiccups therefore warrant not only etiological investigation and multimodal symptom management but also vigilant nutritional assessment. Tailoring enteral access to individual patient factors is essential: jejunal feeding may bypass vomiting risk in the acute phase, while standard gastric feeding can suffice once symptom control permits. Recognizing and addressing secondary complications such as malnutrition is critical to improving both short- and long-term outcomes in this challenging clinical scenario.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Ethics statement
Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and the institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
MK: Investigation, Writing – original draft, Visualization. JM: Data curation, Resources, Supervision, Writing – review & editing. FM: Conceptualization, Data curation, Formal analysis, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was used in the creation of this manuscript. The authors utilized ChatGPT version 4.0 (OpenAI) to enhance language translation, grammar, and spelling. After employing these tools/services, the authors thoroughly reviewed and edited the content as necessary, and take full responsibility for the final content of the publication.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Steger, M, Schneemann, M, and Fox, M. Systemic review: the pathogenesis and pharmacological treatment of hiccups. Aliment Pharmacol Ther. (2015) 42:1037–50. doi: 10.1111/apt.13374,
2. Cole, JA, and Plewa, MC. Singultus. StatPearls. 2023; Available online at: https://www.ncbi.nlm.nih.gov/books/NBK538225/ (Accessed August 1, 2024).
3. Kolodzik, PW, and Filers, MA. Hiccups (singultus): review and approach to management. Ann Emerg Med. (1991) 20:565–73. doi: 10.1016/S0196-0644(05)81620-8,
4. Samuels, L. Hiccup: a ten year review of anatomy, etiology, and treatment. Can Med Assoc J. (1952) 67:315.
6. Swan, HR, and Simoson, LH. Hiccups complicating myocardial infarction. N Engl J Med. (1952) 247:726–8. doi: 10.1056/NEJM195211062471905,
7. Cederholm, T, Bosaeus, I, Barazzoni, R, Bauer, J, Van Gossum, A, Klek, S, et al. Diagnostic criteria for malnutrition - an ESPEN consensus statement. Clin Nutr. (2015) 34:335–40. doi: 10.1016/j.clnu.2015.03.001,
8. Seifi, A, Krishnakumar, HN, Lacci, J, and Fox, MR. Study of demographics and etiological trends in hiccup hospitalizations in the United States during 2005-2018, a cross-sectional study. Am J Emerg Med. (2023) 65:204–6. doi: 10.1016/j.ajem.2022.11.032,
9. Dore, MP, Pedroni, A, Pes, GM, Maragkoudakis, E, Tadeu, V, Pirina, P, et al. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci. (2007) 52:463–8. doi: 10.1007/s10620-006-9573-7,
10. Launois, S, Bizec, JL, Whitelaw, WA, Cabane, J, and Derenne, P. Hiccup in adults: an overview. Eur Respir J. (1993) 6:563–75.
11. MorettoEN, MA. Cochrane Library Cochrane Database of Systematic Reviews Interventions for treating persistent and intractable hiccups in adults (Review). 2019; Available online at: www.cochranelibrary.com (Accessed February 4, 2025).
12. Bendersky, G, and Baren, M. Hypnosis in the termination of hiccups unresponsive to conventional treatment. AMA Arch Intern Med. (1959) 104:417–20. doi: 10.1001/archinte.1959.00270090071012,
13. Walstra, C, and Reynaert, H. Therapeutic gastroscopy in idiopathic persistent hiccups: a case report. (2016). doi: 10.4172/2161-069X.1000400
14. Petroianu, GA. Treatment of hiccup by vagal maneuvers. J Hist Neurosci. (2015) 24:123–36. doi: 10.1080/0964704X.2014.897133,
15. Suliman, A, Paranathala, MP, Kolapo, A, Nath, U, and Hussain, MA. Vagal nerve stimulation for intractable hiccups. J Neurol Res. (2024) 14:86–9.
16. Recio, SZ, and Abdennadher, M. Intractable hiccups after VNS implantation: a case report. BMC Neurol. (2023) 23:23. doi: 10.1186/s12883-023-03352-x
17. Grewal, SS, Adams, AC, and Van Gompel, JJ. Vagal nerve stimulation for intractable hiccups is not a panacea: a case report and review of the literature. Int J Neurosci. (2018) 128:1114–7. doi: 10.1080/00207454.2018.1486307,
19. Lopez, DJ, and Kumar, S. Stellate ganglion block for intractable hiccups secondary to a motor vehicle collision. Cureus. (2023) 15:e37030
20. Ran Lee, A, Cho, YW, Lee, JM, Shin, YJ, Han, IS, and Lee, HK. Treatment of persistent postoperative hiccups with stellate ganglion block: three case reports. Medicine. (2018) 97:1–3. doi: 10.1097/MD.0000000000013370
21. Zhong, Y, Deng, J, Wang, L, and Zhang, Y. Phrenic nerve block combined with stellate ganglion block for postoperative intractable hiccups: a case report. J Int Med Res. (2023) 51:03000605231197069. doi: 10.1177/03000605231197069,
22. Study Details | New Physitherapy or alternative therapy for hiccup|ClinicalTrials.gov. Available online at: https://clinicaltrials.gov/study/NCT05749159?cond=hiccup&rank=1 (Accessed November 25, 2024).
23. Lemée, JM, Chinier, E, Bernard, F, Gallet, C, and Menei, P. Intrathecal baclofen infusion for spastic intractable hiccups. Ann Phys Rehabil Med. (2021) 64:101417. doi: 10.1016/j.rehab.2020.07.003,
24. Chang, FY, and Lu, CL. Hiccup: mystery, nature and treatment. J Neurogastroenterol Motil. (2012) 18:123–30. doi: 10.5056/jnm.2012.18.2.123,
25. Wilcox, SK, Garry, A, and Johnson, MJ. Novel use of amantadine: to treat hiccups. J Pain Symptom Manag. (2009) 38:460–5.
26. Serón-Arbeloa, C, Labarta-Monzón, L, Puzo-Foncillas, J, Mallor-Bonet, T, Lafita-López, A, Bueno-Vidales, N, et al. Malnutrition screening and assessment. Nutrients. (2022) 14:1–21. doi: 10.3390/nu14122392
Keywords: enteral nutrition, gastroesophageal reflux disease, intractable hiccups, nutritional support, PEG-PEJ, severe malnutrition
Citation: Miaśkiewicz K, Janiak M and Folwarski M (2026) Intractable hiccup leading to life-threatening malnutrition: case report. Front. Nutr. 12:1729025. doi: 10.3389/fnut.2025.1729025
Edited by:
Yayun Wang, Air Force Medical University, ChinaReviewed by:
Enrique Cervantes-Pérez, Civil Hospital of Guadalajara, MexicoAndrew Ukleja, Cleveland Clinic Florida, United States
Copyright © 2026 Miaśkiewicz, Janiak and Folwarski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kinga Miaśkiewicz, ay5taWFza2lld2ljekBndW1lZC5lZHUucGw=